Neuburgh Advisers LLC raised its position in shares of Chemed Co. (NYSE:CHE) by 9.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,400 shares of the company’s stock after buying an additional 306 shares during the quarter. Neuburgh Advisers LLC’s holdings in Chemed were worth $1,088,000 at the end of the most recent quarter.
Other institutional investors have also recently made changes to their positions in the company. Bremer Trust National Association purchased a new position in Chemed during the fourth quarter valued at $25,000. Quadrant Capital Group LLC lifted its position in Chemed by 184.8% during the first quarter. Quadrant Capital Group LLC now owns 94 shares of the company’s stock valued at $26,000 after buying an additional 61 shares during the period. Executive Wealth Management LLC purchased a new position in Chemed during the fourth quarter valued at $27,000. Bremer Bank National Association purchased a new position in Chemed during the first quarter valued at $29,000. Finally, Paragon Capital Management LLC purchased a new position in Chemed during the first quarter valued at $40,000. 87.92% of the stock is owned by institutional investors and hedge funds.
In related news, insider Kevin J. Mcnamara sold 6,000 shares of Chemed stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $331.67, for a total value of $1,990,020.00. Following the completion of the sale, the insider now directly owns 159,334 shares in the company, valued at approximately $52,846,307.78. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director George J. Walsh III sold 646 shares of Chemed stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $326.83, for a total value of $211,132.18. Following the completion of the sale, the director now owns 7,070 shares of the company’s stock, valued at $2,310,688.10. The disclosure for this sale can be found here. In the last ninety days, insiders sold 8,046 shares of company stock valued at $2,655,480. 3.96% of the stock is owned by insiders.
CHE opened at $346.66 on Friday. The company has a quick ratio of 0.70, a current ratio of 0.73 and a debt-to-equity ratio of 0.17. The stock has a market capitalization of $5.52 billion, a PE ratio of 29.06, a P/E/G ratio of 3.10 and a beta of 1.11. Chemed Co. has a 1 year low of $260.03 and a 1 year high of $354.43.
Chemed (NYSE:CHE) last posted its quarterly earnings results on Monday, April 29th. The company reported $2.92 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.96 by ($0.04). The company had revenue of $462.03 million during the quarter, compared to analysts’ expectations of $468.28 million. Chemed had a return on equity of 35.19% and a net margin of 11.37%. Chemed’s revenue for the quarter was up 5.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.72 EPS. Sell-side analysts forecast that Chemed Co. will post 12.65 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 19th. Stockholders of record on Thursday, May 30th will be given a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 0.35%. The ex-dividend date of this dividend is Wednesday, May 29th. Chemed’s dividend payout ratio is presently 10.06%.
TRADEMARK VIOLATION NOTICE: “Neuburgh Advisers LLC Purchases 306 Shares of Chemed Co. (NYSE:CHE)” was first reported by Ticker Report and is the sole property of of Ticker Report. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright laws. The correct version of this report can be read at https://www.tickerreport.com/banking-finance/4372401/neuburgh-advisers-llc-purchases-306-shares-of-chemed-co-nyseche.html.
Chemed Company Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations.
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.